Slide CordenPharma scientist in lab coat holding binder for News & Press header with white global connectivity background

NEWS & PRESS


All News & Press

May 9, 2022

CordenPharma COVID-19 Customer Letter

May 09, 2022
COVID-19 > Read CEO Dr. Michael Quirmbach's Customer Letter Response to COVID-19.
May 2, 2022

Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG

May 2, 2022
Press Release > Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG.
April 13, 2022

CordenPharma Receives Supplier Recognition Award from Esperion

April 13, 2022
CordenPharma Receives Supplier Recognition Award from Esperion at DCAT Week 2022.
April 11, 2022

CordenPharma and WACKER To Produce mRNA Vaccines for Germany When Needed

April 11, 2022
Press Release > Wacker & CordenPharma win contract to be stand-by ready to produce mRNA vaccines for German government if needed.
March 14, 2022

CEO Discusses CDMO Capex Growth & Expansion in 2022

Edition 1 / March 2022
CEO Editorial > 2022 & Beyond: Resiliency, Expansion & Growth
March 14, 2022

Corden Connect Interviews New Managing Director Yvan Liard of CordenPharma Fribourg

Edition 1 / March 2022
New Facility Acquisition Video Series > Part 1: Interview with Managing Director Yvan Liard of CordenPharma Fribourg
March 14, 2022

Three New Drug Product Facilities Expand Small Molecules Platform

Edition 1 / March 2022
Small Molecules Platform > Three New Drug Product Facilities Expand & Augment Our Small Molecules Platform
March 14, 2022

LNP Formulation Process Capability Expansion in Caponago

Edition 1 / March 2022
Lipid & Injectable Platforms > New Lipid NanoParticle Formulation Capabilities Bring Flexible Drug Development Options
March 10, 2022

CordenPharma Donates to Support Disaster Relief Efforts in the Ukraine

March 10, 2022
CordenPharma donates a combined €100,000 to support disaster relief efforts in the Ukraine.
March 3, 2022

CEO Michael Quirmbach Talks Expanded Footprint, Green Chemistry & Growth

March 3, 2022
Global Business Reports Interview: CEO Michael Quirmbach Talks 2022 Expanded Footprint & Growth Strategy
March 1, 2022

CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccines

March 1, 2022
Press Release > CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccine Strategy.
January 26, 2022

CordenPharma Completes Acquisition of 3 Facilities from Vifor Pharma

February 1, 2022
Press Release > CordenPharma Completes Acquisition of 3 Facilities from Vifor Pharma
January 18, 2022

CordenPharma Collaborates on Continuous Peptide Manufacturing & Green Chemistry

January 18, 2022
Press Release > CordenPharma Collaborates with PeptiSystems on Green Continuous Peptide Manufacturing.
January 13, 2022

DCAT Value Chain Insights Interviews CEO Michael Quirmbach on 2022 CDMO Key Issues

January 13, 2021
DCAT Value Chain Insights Interview: CEO Michael Quirmbach Talks Trends & Issues in the CDMO Sector for 2022.
December 16, 2021

CordenPharma to Acquire Three Drug Product Manufacturing Facilities from Vifor Pharma

December 16, 2021
Press Release > CordenPharma to Acquire Three Drug Product Manufacturing Facilities from Vifor Pharma